8-K: NeueHealth Reports Mixed Q1 2024 Results, Revenue Declines but Profitability Improves

NeueHealth's first quarter of 2024 saw a decrease in revenue compared to the previous year, but the company achieved net income and positive adjusted EBITDA.

Summary

• NeueHealth reported a revenue of $245.1 million for the first quarter of 2024, a decrease from $300.6 million in the same period last year.
• The company achieved a net income from continuing operations of $5.7 million, a significant improvement from a loss of $53.9 million in Q1 2023.
• Adjusted EBITDA for Q1 2024 was $2.5 million, compared to a loss of $5.7 million in the first quarter of 2023.
• The company is maintaining its full-year 2024 Adjusted EBITDA guidance of between $15 million and $25 million.
• NeueHealth served 360,000 value-based consumers in Q1 2024, down from 373,000 in Q1 2023.
• Enablement services lives increased significantly to 109,000 from 27,000 in the same period last year.
• The company expects full-year 2024 revenue to be approximately $1 billion, with NeueCare revenue between $310 million and $320 million and NeueSolutions revenue between $690 million and $700 million.
• The adjusted operating cost ratio is expected to be between 19% and 20% including corporate costs.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to the improvement in profitability and maintained guidance, but the revenue decline and risks temper the overall outlook.

Positives

• The company achieved net income from continuing operations of $5.7 million, a significant improvement from the loss in the same quarter last year.
• Adjusted EBITDA turned positive at $2.5 million, indicating improved operational efficiency.
• Enablement services lives saw a substantial increase, suggesting growth in that segment.
• The company is maintaining its full-year Adjusted EBITDA guidance, indicating confidence in future performance.

Negatives

• Revenue decreased to $245.1 million in Q1 2024 from $300.6 million in Q1 2023.
• The number of value-based consumers served decreased to 360,000 from 373,000 year-over-year.
• The adjusted operating cost ratio is expected to be between 19% and 20% including corporate costs.

Risks

• The company's ability to continue as a going concern is a risk factor.
• There are risks associated with the company's ability to comply with the terms of its credit facility.
• The company's ability to receive the remaining proceeds from the sale of its Medicare Advantage business in California in a timely manner is a risk.
• The company's ability to obtain short or long-term debt or equity financing is a risk.
• The company faces risks related to the wind down of its IFP and MA businesses outside of California.
• Potential disruptions to the business due to corporate restructuring and headcount reduction are a risk.
• The company's ability to accurately estimate and manage costs related to changes in business offerings is a risk.
• A delay or inability to withdraw regulated capital from subsidiaries is a risk.
• There is a risk of a lack of acceptance or slow adoption of the company's business model.
• The company's ability to retain existing consumers and expand enrollment is a risk.
• The company's ability to accurately assess, code, and report risk adjustment factor scores is a risk.
• The company's ability to contract with care providers and arrange for quality care is a risk.
• The company's ability to accurately estimate medical expenses and manage costs is a risk.
• The company's ability to obtain claims information timely and accurately is a risk.
• The impact of any pandemic or epidemic on the business is a risk.
• The company's reliance on third-party providers is a risk.
• The impact of modifications or changes to the U.S. health insurance markets is a risk.
• The company's ability to manage growth is a risk.
• The company's ability to operate, update, or implement its technology platform is a risk.
• The company's ability to retain key executives is a risk.
• The company's ability to successfully pursue acquisitions and integrate acquired businesses is a risk.
• The occurrence of severe weather events, catastrophic health events, natural or man-made disasters, and social and political conditions or civil unrest are risks.
• The company's ability to prevent and contain data security incidents is a risk.
• The company's ability to comply with requirements to maintain effective internal controls is a risk.
• The company's ability to adapt to mitigate risks associated with its ACO Reach businesses is a risk.

Future Outlook

NeueHealth expects to continue to drive long-term, sustainable growth in both its NeueCare and NeueSolutions segments this year and maintains its full-year 2024 Adjusted EBITDA guidance of between $15 million and $25 million. The company expects full-year 2024 revenue to be approximately $1 billion.

Management Comments

• Mike Mikan, President and CEO of NeueHealth, stated that the company had a strong start to the year, continuing to advance their value-driven, consumer-centric care model.
• He also mentioned that they expanded operations in Central Florida and continue to focus on proactive consumer engagement.

Industry Context

The healthcare industry is increasingly focused on value-based care models, and NeueHealth's emphasis on this approach aligns with broader industry trends. The company's focus on consumer-centric care and partnerships with providers and payors is also a common theme in the current healthcare landscape.

Comparison to Industry Standards

• While NeueHealth's revenue decreased year-over-year, the improvement in net income and adjusted EBITDA suggests progress in operational efficiency, which is a key focus for healthcare companies.
• Companies like Oak Street Health and Agilon Health also operate in the value-based care space, and their financial performance is often compared to NeueHealth's.
• The growth in enablement services lives is a positive sign, as this is a key area for many healthcare technology and services companies.
• The company's full-year guidance for revenue and adjusted EBITDA will be closely watched by investors to assess its performance against industry benchmarks.

Stakeholder Impact

• Shareholders will be impacted by the mixed financial results, with the improved profitability being a positive sign but the revenue decline being a concern.
• Employees may be affected by the ongoing restructuring and potential headcount reductions.
• Customers will benefit from the company's focus on consumer-centric care and expanded operations.
• Providers and payors will be impacted by the company's partnerships and value-based care model.
• Creditors will be impacted by the company's ability to comply with its credit facility and manage its debt.

Next Steps

• NeueHealth will discuss the company's results, strategy, and outlook on a conference call with investors.
• The company will continue to focus on proactive consumer engagement and expanding its operations.

Key Dates

Keywords

Healthcare, Value-Based Care, Medicare, Medicaid, ACA Marketplace, Adjusted EBITDA, Revenue, Net Income, Financial Results, NeueHealth